What does Balyasny Asset Management L.p. invest in?
Balyasny Asset Management L.p. invests most often at Series C and Series B (67% of the rounds on record), in sectors such as FinTech and Food And Beverage.
United States · Investor
Last cheque observed Oct 2026; 7 cheques on record.
Follow Balyasny Asset Management L.p. and see its new cheques in your feed.Sign up free
Deploying nowPrivate equity
3 cheques in the last 12 months
Mostly Series C and Series B: 67% of its rounds
1 exits from the portfolio
Every round we can evidence, newest first7 appearances
2 rounds
2 rounds
1 round
1 round
1 round
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
We hold 37 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
Companies it backed that were later bought or listed1 in all
An exit counts when it came after the firm's first round in the company. From historical deal records.
The investors most often in the same rounds as Balyasny Asset Management L.p.. A count of rooms they were both in, not a relationship either has claimed.
The latest companies Balyasny Asset Management L.p. put money into.
Balyasny Asset Management L.p. invests most often at Series C and Series B (67% of the rounds on record), in sectors such as FinTech and Food And Beverage.
7 investments on record, 3 of them in the last 12 months. The most recent was in Oct 2026.
Its most recent investments on record: Zai Lab (Undisclosed round, Oct 2026), Soufflé Therapeutics (Series B, Oct 2026) and Aspen Neuroscience (Series C, Nov 2025).
The median round it joins is $238M.
Rarely, if at all: none of its 7 investments on record names it as the lead.
Most of the companies it backs are in the United States (86%) and China (14%).
Yes: it is actively investing, with 3 investments in the last 12 months.
Most often ARCH Venture Partners (2 rounds together), Cormorant Asset Management (2 rounds together) and Frazier Life Sciences (2 rounds together).
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it